Bausch Health Companies (BHC) Assets Average (2010 - 2026)
Bausch Health Companies (BHC) posted Assets Average of $24.6 billion for Q2 2026, down 3.09% sequentially from $25.4 billion in Q1 2026, and down 8.19% YoY from $26.8 billion in Q2 2025.
Bausch Health Companies (BHC) Assets Average (2010 - 2026) Analysis & Trends
Bausch Health Companies has reported Assets Average for 17 years, with the latest figure at $24.6 billion in Q2 2026.
- Quarterly Assets Average fell 8.19% year-over-year to $24.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $24.6 billion (down 8.19% YoY) and the FY2025 annual result came in at $26.4 billion, down 1.83% from the prior year.
- Assets Average eased to $24.6 billion in Q2 2026 per BHC's latest filing, from $25.4 billion in the prior quarter.
- Over five years, Assets Average peaked at $29.1 billion in Q1 2022 and troughed at $24.6 billion in Q2 2026.
- A 5-year average of $26.6 billion and a median of $26.6 billion in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2023 and 2024: Assets Average declined 12.28% in 2023, then grew 6.13% in 2024.
- Over 5 years, Assets Average stood at $26.0 billion in 2022, then climbed by 4.67% to $27.2 billion in 2023, then dropped by 2.48% to $26.5 billion in 2024, then climbed by 0.24% to $26.6 billion in 2025, then declined by 7.33% to $24.6 billion in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $24.6 billion, $25.4 billion, and $26.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Bausch Health Companies | 2.57 Bn | 734.50 Mn | 2.10 Bn | 24.65 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.65 Bn |
| Mar 31, 2026 | 25.43 Bn |
| Dec 31, 2025 | 26.60 Bn |
| Sep 30, 2025 | 27.05 Bn |
| Jun 30, 2025 | 26.84 Bn |
| Mar 31, 2025 | 26.47 Bn |
| Dec 31, 2024 | 26.53 Bn |
| Sep 30, 2024 | 26.52 Bn |
| Jun 30, 2024 | 26.70 Bn |
| Mar 31, 2024 | 27.13 Bn |
| Dec 31, 2023 | 27.21 Bn |
| Sep 30, 2023 | 26.28 Bn |
| Jun 30, 2023 | 25.47 Bn |
| Mar 31, 2023 | 25.57 Bn |
| Dec 31, 2022 | 25.99 Bn |
| Sep 30, 2022 | 27.23 Bn |
| Jun 30, 2022 | 28.63 Bn |
| Mar 31, 2022 | 29.15 Bn |
| Dec 31, 2021 | 29.23 Bn |
| Sep 30, 2021 | 29.65 Bn |